In the group of patients with asthma exacerbation, TSLP levels decreased following OCS treatment in the steroid responders' group; however, in the group of paradoxical responders, TSLP levels did not decrease after OCS treatment during asthma exacerbation (62). The gene discussed is TSLP; the disease is asthma.